Alexion Pharmaceuticals

  • Previous Rank
    815
  • Revenues ($M)
    3084
  • Revenue Percent Change
    18.4
  • Profits ($M)
    399
  • Profits Percent Change
    176.3
  • Assets ($M)
    13253
  • Employees
    3121
  • Market Value — as of March 31, 2017 ($M)
    27297

Company Info

CEOLudwig N. Hantson
CEO TitleChief Executive Officer & Director
SectorHealth Care
IndustryPharmaceuticals
HQ LocationNew Haven, CT
Websitewww.alexion.com
Years on Fortune 500 List-
Employees3,121

Key Financials (Last Fiscal Year)

Revenues ($M)$3,084
Profits ($M)$399
Assets ($M)$13,253
Total Stockholder Equity ($M)$8,694
Market Value — as of March 31, 2017 ($M)$27,297

Profit Ratios

Profit as % of Revenues12.9%
Profits as % of Assets3%
Profits as % of Stockholder Equity4.6%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)1.76
EPS % Change (from 2015)162.7%
EPS % Change (5 year annual rate)14.1%
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2016)-35.9%
Total Return to Investors (5 year, annualized)11.3%
Total Return to Investors (10 year, annualized)28.3%